메뉴 건너뛰기




Volumn 64, Issue 9, 2005, Pages 1514-1519

The ability of persons with Alzheimer disease (AD) to make a decision about taking an AD treatment

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; CAREGIVER; CLINICAL ARTICLE; COGNITION; COMPETENCE; CONTROLLED STUDY; DECISION MAKING; DISEASE SEVERITY; FEMALE; HUMAN; INTERVIEW; MALE; MEMORY DISORDER; PERFORMANCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; SCORING SYSTEM; SENSITIVITY ANALYSIS; SYMPTOM;

EID: 18144383893     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/01.WNL.0000160000.01742.9D     Document Type: Review
Times cited : (164)

References (27)
  • 4
    • 0036085343 scopus 로고    scopus 로고
    • Current state of research on decision-making competence of cognitively impaired elderly persons
    • Kim SY, Karlawish JH, Caine ED. Current state of research on decision-making competence of cognitively impaired elderly persons. Am J Geriatr Psychiatry 2002;10:151-165.
    • (2002) Am J Geriatr Psychiatry , vol.10 , pp. 151-165
    • Kim, S.Y.1    Karlawish, J.H.2    Caine, E.D.3
  • 5
    • 0029116799 scopus 로고
    • Assessing the competency of patients with Alzheimer's disease under different legal standards: A prototype instrument
    • Marson DC, Ingram KK, Cody HA, Harrell LE. Assessing the competency of patients with Alzheimer's disease under different legal standards: a prototype instrument. Arch Neurol 1995;52:949-954.
    • (1995) Arch Neurol , vol.52 , pp. 949-954
    • Marson, D.C.1    Ingram, K.K.2    Cody, H.A.3    Harrell, L.E.4
  • 6
    • 0032602771 scopus 로고    scopus 로고
    • Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer's disease
    • Marson D, Harrell L. Executive dysfunction and loss of capacity to consent to medical treatment in patients with Alzheimer's disease. Semin Clin Neuropsychol 1999;4:41-49.
    • (1999) Semin Clin Neuropsychol , vol.4 , pp. 41-49
    • Marson, D.1    Harrell, L.2
  • 7
    • 0029988594 scopus 로고    scopus 로고
    • Toward a neurologic model of competency: Cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards
    • Marson DC, Chatterjee A, Ingram KK, Harrell LE. Toward a neurologic model of competency: cognitive predictors of capacity to consent in Alzheimer's disease using three different legal standards. Neurology 1996;46:666-672.
    • (1996) Neurology , vol.46 , pp. 666-672
    • Marson, D.C.1    Chatterjee, A.2    Ingram, K.K.3    Harrell, L.E.4
  • 8
    • 0030888115 scopus 로고    scopus 로고
    • Cognitive models that predict physician judgments of capacity to consent in mild Alzheimer's disease
    • Marson DC, Hawkins L, McInturff B, Harrell LE. Cognitive models that predict physician judgments of capacity to consent in mild Alzheimer's disease. J Am Geriatr Soc 1997;45:458-464.
    • (1997) J Am Geriatr Soc , vol.45 , pp. 458-464
    • Marson, D.C.1    Hawkins, L.2    McInturff, B.3    Harrell, L.E.4
  • 9
    • 0036901261 scopus 로고    scopus 로고
    • Alzheimer's disease patients' and caregivers' capacity, competency and reasons to enroll in an early phase Alzheimer's disease clinical trial
    • Karlawish JHT, Casarett DJ, James BD. Alzheimer's disease patients' and caregivers' capacity, competency and reasons to enroll in an early phase Alzheimer's disease clinical trial. J Am Geriatr Soc 2002;50:2019-2024.
    • (2002) J Am Geriatr Soc , vol.50 , pp. 2019-2024
    • Karlawish, J.H.T.1    Casarett, D.J.2    James, B.D.3
  • 10
    • 10744230547 scopus 로고    scopus 로고
    • Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization
    • Orgogozo JM, Gilman S, Dartigues JF, et al. Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 2003;61:46-54.
    • (2003) Neurology , vol.61 , pp. 46-54
    • Orgogozo, J.M.1    Gilman, S.2    Dartigues, J.F.3
  • 13
    • 0037044231 scopus 로고    scopus 로고
    • Rates of progression in mild cognitive impairment and early Alzheimer's disease
    • Storandt M, Grant EA, Miller JP, Morris JC. Rates of progression in mild cognitive impairment and early Alzheimer's disease. Neurology 2002;59:1034-1041.
    • (2002) Neurology , vol.59 , pp. 1034-1041
    • Storandt, M.1    Grant, E.A.2    Miller, J.P.3    Morris, J.C.4
  • 14
    • 0021271971 scopus 로고
    • Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease
    • McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan E. Clinical diagnosis of Alzheimer's disease. Report of the NINCDS-ADRDA Work Group under auspices of the Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984;34:939-944.
    • (1984) Neurology , vol.34 , pp. 939-944
    • McKhann, G.1    Drachman, D.2    Folstein, M.3    Katzman, R.4    Price, D.5    Stadlan, E.6
  • 15
    • 0016823810 scopus 로고
    • Mini-Mental State: A practical method for grading the cognitive state of patients for the clinician
    • Folstein M, Folstein S, McHugh P. Mini-Mental State: a practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
    • (1975) J Psychiatr Res , vol.12 , pp. 189-198
    • Folstein, M.1    Folstein, S.2    McHugh, P.3
  • 16
    • 2642533779 scopus 로고    scopus 로고
    • How does an Alzheimer's disease patient's role in medical decision-making change over time?
    • Hirschman KB, Xie SX, Feudtner C, Karlawish JHT. How does an Alzheimer's disease patient's role in medical decision-making change over time? J Geriatr Psychol Neurol 2004;75:55-60.
    • (2004) J Geriatr Psychol Neurol , vol.75 , pp. 55-60
    • Hirschman, K.B.1    Xie, S.X.2    Feudtner, C.3    Karlawish, J.H.T.4
  • 17
    • 0030967165 scopus 로고    scopus 로고
    • A controlled trial of selegeline, alpha-tocopherol, or both as treatment for Alzheimer's disease
    • Sano M, Ernesto C, Thomas RG, et al. A controlled trial of selegeline, alpha-tocopherol, or both as treatment for Alzheimer's disease. N Engl J Med 1997;336:1216-1222.
    • (1997) N Engl J Med , vol.336 , pp. 1216-1222
    • Sano, M.1    Ernesto, C.2    Thomas, R.G.3
  • 18
    • 0034633686 scopus 로고    scopus 로고
    • Caregivers' preferences for the treatment of patients with Alzheimer's disease
    • Karlawish JHT, Klocinski J, Merz JF, Clark CM, Asch D. Caregivers' preferences for the treatment of patients with Alzheimer's disease. Neurology 2000;55:1008-1014.
    • (2000) Neurology , vol.55 , pp. 1008-1014
    • Karlawish, J.H.T.1    Klocinski, J.2    Merz, J.F.3    Clark, C.M.4    Asch, D.5
  • 20
    • 0035003003 scopus 로고    scopus 로고
    • Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research
    • Kim SYH, Caine ED, Currier GW, Leibovici A, Ryan JM. Assessing the competence of persons with Alzheimer's disease in providing informed consent for participation in research. Am J Psychiatry 2001;158:710-717.
    • (2001) Am J Psychiatry , vol.158 , pp. 710-717
    • Kim, S.Y.H.1    Caine, E.D.2    Currier, G.W.3    Leibovici, A.4    Ryan, J.M.5
  • 21
    • 0029911681 scopus 로고    scopus 로고
    • Performance of the Dementia Severity Rating Scale: A caregiver's questionnaire for rating severity in Alzheimer's disease
    • Clark C, Ewbank D. Performance of the Dementia Severity Rating Scale: a caregiver's questionnaire for rating severity in Alzheimer's disease. Alzheimer Dis 1996;10:31-39.
    • (1996) Alzheimer Dis , vol.10 , pp. 31-39
    • Clark, C.1    Ewbank, D.2
  • 22
    • 3342884112 scopus 로고    scopus 로고
    • College Station, TX: Stata
    • STATA Corp. STATA user's guide. Release 8. College Station, TX: Stata, 2003.
    • (2003) STATA User's Guide. Release 8
  • 23
    • 0017360990 scopus 로고
    • The measurement of observer agreement for categorical data
    • Landis JR, Koch GG. The measurement of observer agreement for categorical data. Biometrics 1977;33:159-174.
    • (1977) Biometrics , vol.33 , pp. 159-174
    • Landis, J.R.1    Koch, G.G.2
  • 25
    • 0032903099 scopus 로고    scopus 로고
    • Assessment of patient competency to consent to treatment
    • Etchells E, Darzins P, Silberfeld M, et al. Assessment of patient competency to consent to treatment. J Gen Intern Med 1999;14:27-34.
    • (1999) J Gen Intern Med , vol.14 , pp. 27-34
    • Etchells, E.1    Darzins, P.2    Silberfeld, M.3
  • 26
    • 0036789018 scopus 로고    scopus 로고
    • Utility and limits of the Mini Mental State Examination in evaluating consent capacity in Alzheimer's disease
    • Kim SY, Caine ED. Utility and limits of the Mini Mental State Examination in evaluating consent capacity in Alzheimer's disease. Psychiatr Serv 2002;53:1322-1324.
    • (2002) Psychiatr Serv , vol.53 , pp. 1322-1324
    • Kim, S.Y.1    Caine, E.D.2
  • 27
    • 0028848188 scopus 로고
    • Competence of long-term care residents to participate in decisions about their medical care: A brief, objective assessment
    • Pruchno RA, Smyer MA, Rose MS, Hartman-Stein PE, Henderson-Laribee DL. Competence of long-term care residents to participate in decisions about their medical care: a brief, objective assessment. Gerontologist 1995;35:622-629.
    • (1995) Gerontologist , vol.35 , pp. 622-629
    • Pruchno, R.A.1    Smyer, M.A.2    Rose, M.S.3    Hartman-Stein, P.E.4    Henderson-Laribee, D.L.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.